This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend DPC

If you are a person with diabetes, or would like more information on diabetes, please refer to our partner charity, the Diabetes Research & Wellness Foundation (DRWF).

Visit Charity?

News

IMAGE

01 Jun 2020

GPs urged to be more ‘proactive’ to prevent heart failure in people with diabetes

“Be proactive, not reactive,” that’s the message from GPwSIs Dr Naresh Kanumilli who is trying to encourage more heart failure awareness among those with diabetes.

Based in Manchester, the general practitioner has signed up to host an online webinar for healthcare professionals on Thursday, June 25 at 12:30pm, about his specialist subjects diabetes and cardiology.

REGISTER HERE

He will be using his hour-long session entitled ‘Managing Cardiovascular Risk in Patients With Type 2 Diabetes, Evidence into Primary Care’ to urge other doctors to be “proactive” when it comes to finding people with type 2 diabetes who could be at risk of developing heart failure.

He said: “Just because we’re in the middle of a pandemic, doesn’t mean we stop managing people with diabetes to the best of our ability. We all need to be more aware that heart failure is extremely common among people with diabetes and yet it very often goes undiagnosed.

“We ned to be actively looking for these patients because prevention is cure. Virtual consultations can be used to help us to be proactive during these strange times, it’s just about knowing what to ask and what to look for.”

Dr Kanumilli has done a lot of work in this area and even carried out a small audit among his GP practice to further investigate how early intervention could have a positive impact on people’s health.   

He said: “We searched our practice register for people who have type 2 diabetes and we applied certain criteria, such as shortness of breath, medication, duration of diabetes, insulin usage and previous known experience with therapies, to determine their heart failure risk.

“Once identified we then put a protocol in place, inviting these people into the surgery so we could introduce them to SGLT2 inhibitors or GLP-1 Agonists. What we’re trying to do here is introduce these medications early on in the disease cycle in a bid to improve health outcomes and reduce unplanned admissions for the persons living with diabetes.”

Managing Cardiovascular Risk in Patients With Type 2 Diabetes, Evidence into Primary Care will take place on Thursday, June 25 at 12:30pm. Prior registration is required. Click here to register.

REGISTER HERE

View all News
Loading

Twitter

Sponsors

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Abbott

 

Gold & Wifi Sponsor

  • GlucoRX

 

Gold Sponsor

  • Roche

 

Gold Sponsor

  • Insulet

 

The InterACT Diabetes Village

  • AstraZeneca

 

Registration Sponsor

  • Diabetes Research & Wellness Foundation

 

Partners

Event Partner

  • NHS

Event Partner

  • ABCD

Event Partner

  • Diabetes Times

Event Partner

  • Trend

Media Partner

  • Caring Uk

Media Partner

  • Care Hub

Media Partner

  • Lifestyle Hub

Media Partner

  • Hospital Hub

Media Partner

  • Hub News

Media Partner

  • Practical Diabetes

Media Partner

  • Prescriber